These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 2426287

  • 1. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M, Mayer M, Schirrmacher V, Vlodavsky I.
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [Abstract] [Full Text] [Related]

  • 2. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M, Kramer MD, Schirrmacher V, Ishai-Michaeli R, Fuks Z, Vlodavsky I.
    Int J Cancer; 1985 Apr 15; 35(4):483-91. PubMed ID: 3157649
    [Abstract] [Full Text] [Related]

  • 3. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
    Eldor A, Bar-Ner M, Yahalom J, Fuks Z, Vlodavsky I.
    Semin Thromb Hemost; 1987 Oct 15; 13(4):475-88. PubMed ID: 3321438
    [Abstract] [Full Text] [Related]

  • 4. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N, Disatnik MH, Nevo Z.
    J Cell Physiol; 1987 Jan 15; 130(1):77-84. PubMed ID: 3805131
    [Abstract] [Full Text] [Related]

  • 5. Heparanase activity in cultured endothelial cells.
    Godder K, Vlodavsky I, Eldor A, Weksler BB, Haimovitz-Freidman A, Fuks Z.
    J Cell Physiol; 1991 Aug 15; 148(2):274-80. PubMed ID: 1880155
    [Abstract] [Full Text] [Related]

  • 6. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M, Mohsen M, Levi E, Wygoda MR, Miao HQ, Lider O, Svahn CM, Ekre HP, Ishai-Michaeli R, Bar-Shavit R.
    Isr J Med Sci; 1995 Aug 15; 31(2-3):106-18. PubMed ID: 7744578
    [Abstract] [Full Text] [Related]

  • 7. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.
    Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V.
    Cancer Res; 1983 Jun 15; 43(6):2704-11. PubMed ID: 6601984
    [Abstract] [Full Text] [Related]

  • 8. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z.
    Invasion Metastasis; 1992 Jun 15; 12(2):112-27. PubMed ID: 1399400
    [Abstract] [Full Text] [Related]

  • 9. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G, Bjornsson TD, Vlodavsky I.
    J Cell Physiol; 1993 Mar 15; 154(3):456-65. PubMed ID: 8436596
    [Abstract] [Full Text] [Related]

  • 10. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M, Vlodavsky I, Bar-Shavit R.
    Exp Cell Res; 1992 Jul 15; 201(1):208-15. PubMed ID: 1612123
    [Abstract] [Full Text] [Related]

  • 11. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
    Matzner Y, Bar-Ner M, Yahalom J, Ishai-Michaeli R, Fuks Z, Vlodavsky I.
    J Clin Invest; 1985 Oct 15; 76(4):1306-13. PubMed ID: 2997275
    [Abstract] [Full Text] [Related]

  • 12. Involvement of heparanase in tumor metastasis and angiogenesis.
    Vlodavsky I, Michaeli RI, Bar-Ner M, Fridman R, Horowitz AT, Fuks Z, Biran S.
    Isr J Med Sci; 1988 Oct 15; 24(9-10):464-70. PubMed ID: 2462549
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, Vigoda M, Ishai-Michaeli R, Peretz T.
    Invasion Metastasis; 1988 Oct 15; 14(1-6):290-302. PubMed ID: 7657522
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.
    Niedbala MJ, Sartorelli AC.
    Cancer Commun; 1990 Oct 15; 2(5):189-99. PubMed ID: 2142433
    [Abstract] [Full Text] [Related]

  • 15. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
    Fridman R, Lider O, Naparstek Y, Fuks Z, Vlodavsky I, Cohen IR.
    J Cell Physiol; 1987 Jan 15; 130(1):85-92. PubMed ID: 2433294
    [Abstract] [Full Text] [Related]

  • 16. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D.
    J Cell Physiol; 1997 Sep 15; 172(3):334-42. PubMed ID: 9284953
    [Abstract] [Full Text] [Related]

  • 17. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
    Yahalom J, Fibach E, Bar-Tana R, Fuks Z, Vlodavsky I.
    Leuk Res; 1988 Sep 15; 12(9):711-7. PubMed ID: 2973542
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.